Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Submit Your Research
Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Review
August 01, 2011
JTCB. 2011 Aug 1; 9 (2) : 067-075
69 97
PDF (TÜRKÇE)

Intestinal Cholesterol Transport Proteins

Emine Bozkurt1, Ceyda Kabaroğlu2
1 Ege Üniversitesi Tıp Fakültesi Hastanesi, Tıbbi Biyokimya Anabilim Dalı, İzmir
2 Ege Üniversitesi Tıp Fakültesi Hastanesi, Tıbbi Biyokimya Anabilim Dalı, Klinik Biyokimya Bilim Dalı, İzmir

Abstract

The direct link between cardiovascular disease and plasma cholesterol levels has been clearly described. Therapeutic interventions for lowering plasma cholesterol levels have a great significance in prevention of cardiovascular diseases. In enterocytes, numerous transport molecules in charge of cholesterol absorption are defined. These are; fatty acid translocase /cluster determinant 36 (FAT/CD36), scavenger receptor class B type 1 (SR-B1), Nieman Pick C1-Like 1 (NPC1L1), ATP Binding Cassette transporter family (ABCA1,ABCB1,ABCG5/ABCG8), caveolin-1(CAV1) and annexin-2 (ANXA2). Studies highlighting functional aspects and metabolic regulations of intestinal cholesterol transport proteins may reveal new strategies in preventing and/or therapeutic interventions for cardiovascular and cerebrovascular diseases. In this review, recent experimental and clinical information on intestinal cholesterol transport proteins have been summarized.

Keywords

Cholesterol Niemann Pick Disease ezetimibe

Citation

ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Bozkurt, Emine, and Ceyda Kabaroğlu. 2011. “Intestinal Cholesterol Transport Proteins”. Journal of Turkish Clinical Biochemistry 9 (2):067-075. https://turkclinbiochem.org/index.php/pub/article/view/156.
Endnote/Zotero/Mendeley (RIS) BibTeX

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.

© 2026 Journal of Turkish Clinical Biochemistry. All rights reserved.